The political economy of the assessment of value of new health technologies
| Autor: | Jonathan Karnon, Hossein Haji Ali Afzali, Laura Catherine Edney |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Financing
Government Opportunity cost Technology Assessment Biomedical Emerging technologies Cost-Benefit Analysis Decision Making 03 medical and health sciences Politics 0302 clinical medicine Humans 030212 general & internal medicine Government spending Cost–benefit analysis Public economics 030503 health policy & services Health Policy Public Health Environmental and Occupational Health Health technology Quality-adjusted life year England Public Opinion Economic evaluation Insurance Health Reimbursement Business Quality-Adjusted Life Years 0305 other medical science |
| Zdroj: | Journal of health services researchpolicy. 23(2) |
| ISSN: | 1758-1060 |
| Popis: | Health technology assessment provides a common framework for evaluating the costs and benefits of new health technologies to inform decisions on the public funding of new pharmaceuticals and other health technologies. In Australia and England, empirical analyses of the opportunity costs of government spending on new health technologies suggest more quality adjusted life years are being forgone than are being gained by a non-trivial proportion of funded health technologies. This essay considers the relevance of available empirical estimates of opportunity costs and explores the relationship between the public funding of health technologies and broader political and economic factors. We conclude that the benefits of a general reduction in the prices paid by governments for new technologies outweigh the costs, but evidence of informed public acceptance of reduced access to new health technologies may be required to shift the current approach to assessing the value of new health technologies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|